Merck to sell Consumer Health to Procter & Gamble
Merck has sold its global Consumer Health business to Procter & Gamble
Advent in negotiations to acquire Sanofi’s generics business
Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,
Certara acquires Analytica Laser
Certara announced it has acquired Analytica Laser which uses health economics and outcomes research (HEOR)
Mylan partners with Fujifilm Kyowa Kirin Biologics
Mylan partners with Fujifilm Kyowa Kirin Biologics to commercialise a biosimilar to Humira®
GSK buys out Novartis’ stake in Consumer Healthcare
GlaxoSmithKline plc have announced that it has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint...
Nanologica & Sterling partnership furthers new business venture
Nanologica AB has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of...
Evotec & Sanofi in talks to create open innovation R&D platform
Evotec and Sanofi enter into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform in France
In...
GSK buys out Novartis’ stake in Consumer Healthcare
GSK Announce agreement with Novartis for the buyout of their Consumer Healthcare
AbbVie and International Myeloma Foundation announce partnership
AbbVie and the International Myeloma Foundation Announce Partnership
MSD and Sun enter generics partnership
MSD and Sun Pharmaceutical Industries have entered into a joint venture to bring branded generics to emerging markets. The partnership will see...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...